ImmunomeIMNM
那斯達克 · USD
28.75
-0.64
(-2.16%)
收盤 08/27 03:59 (UTC+8)
盤後
28.75
28.75
(0.00%)
08/27 03:59 (UTC+8)
ImmunomeIMNM
28.75
-0.64
(-2.16%)
財務數據
損益表
- 0.01
- 0.02
- 0.03
- 0.03
- 0.03
- 0.04
- -
- -
- -
- -
- -73.11
- 129.74
- 23.10
- -5.91
- 6.87
- 37.22
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | 4,015 | 2,926 | 2,738 | 2,910 | 2,364 | 1,029 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | 4,015 | 2,926 | 2,738 | 2,910 | 2,364 | 1,029 |
營業費用 | 78,135 | 59,331 | 72,861 | 60,138 | 50,493 | 47,562 | - | - | - | 133,328 |
研發費用 | 59,885 | 46,381 | 50,770 | 49,193 | 40,451 | 36,872 | 47,890 | 37,200 | 29,083 | 15,369 |
推銷及管理費用 | 18,250 | 12,950 | 12,091 | 10,945 | 10,042 | 10,690 | 10,446 | 9,526 | 6,978 | 6,005 |
非經常性項目費用 | - | - | 10,000 | - | - | - | 27,372 | 6,706 | 6,312 | 111,954 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -78,135 | -59,331 | -72,861 | -60,138 | -46,478 | -44,636 | -82,970 | -50,522 | -40,009 | -132,299 |
其他收入及費用 | 5,008 | 5,492 | 2,961 | 2,681 | 3,081 | 2,996 | 2,721 | 3,422 | 3,887 | 2,807 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -73,127 | -53,839 | -69,900 | -57,457 | -43,397 | -41,640 | -80,249 | -47,100 | -36,122 | -129,492 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -73,127 | -53,839 | -69,900 | -57,457 | -43,397 | -41,640 | -80,249 | -47,100 | -36,122 | -129,492 |
基本每股稅後盈餘(元) | -0.65 | -0.48 | -0.76 | -0.65 | -0.50 | -0.52 | -1.11 | -0.78 | -0.60 | -2.51 |
稀釋每股稅後盈餘(元) | -0.64 | -0.48 | -0.75 | -0.66 | -0.50 | -0.52 | -1.28 | -0.75 | -0.46 | -2.51 |
基本平均股數(千股) | 113272.00 | 113136.00 | 95026.00 | 87957.00 | 87010.00 | 79410.00 | 62872.00 | 60205.00 | 59936.00 | 51544.00 |
稀釋平均股數(千股) | 113272.00 | 113136.00 | 95026.00 | 87957.00 | 87010.00 | 79410.00 | 62872.00 | 60205.00 | 59936.00 | 51544.00 |
還原基本每股稅後盈餘(元) | -0.65 | -0.48 | -0.76 | -0.65 | -0.50 | -0.52 | -1.11 | -0.78 | -0.60 | -2.51 |
還原稀釋每股稅後盈餘(元) | -0.64 | -0.48 | -0.75 | -0.66 | -0.50 | -0.52 | -1.28 | -0.75 | -0.46 | -2.51 |
還原基本平均股數(千股) | 113,272 | 113,136 | 95,026 | 87,957 | 87,010 | 79,410 | 62,872 | 60,205 | 59,936 | 51,544 |
還原稀釋平均股數(千股) | 113,272 | 113,136 | 95,026 | 87,957 | 87,010 | 79,410 | 62,872 | 60,205 | 59,936 | 51,544 |
EBITDA(千元) | -72,412 | -53,086 | -69,124 | -57,540 | -43,882 | -41,732 | -80,190 | -48,002 | -35,801 | -129,767 |